Supreme Court Won't Hear Big Tobacco's Challenge to Cigarette Warning Labels
By Ernie Mundell HealthDay Reporter
MONDAY, Nov. 25, 2024 -- The U.S. Supreme Court on Monday declined to hear a major tobacco company's challenge to a federal law that would mandate graphic images on cigarette packs.
Some of the proposed images include a woman with a large lump on her neck alongside the message "WARNING: Smoking causes head and neck cancer;" lungs blackened by smoking; and feet darkened by smoking-linked circulatory problems.
The R.J. Reynolds tobacco company had filed an appeal with the Supreme Court after the 5th U.S. Circuit Court of Appeals ruled that the warnings do not violate the First Amendment, the Associated Press reported.
In its appeal, the tobacco company argued that some of the images were misleading -- for example, the company claimed that the woman with the lump on her neck would never have let it get that large before going to a doctor.
But the Supreme Court justices ruled that the images do, in fact, reflect the very real hazards of smoking.
If the images make it to the sides of cigarette packs, the U.S. would join 120 other nations that already mandate such graphic warnings. Studies have shown that images work even better than text warnings in cutting down smoking rates.
In a statement, the Campaign for Tobacco-Free Kids called the Supreme Court's dismissal of the appeal a "tremendous victory for public health."
"Graphic warnings are a best-practice policy to reduce tobacco use and save lives, and they are long-overdue in the United States," the advocacy group wrote. "These warnings were first required by Congress in 2009 and have been repeatedly delayed by tobacco industry legal challenges. The graphic warnings will show and tell the truth about the deadly consequences of smoking and will promote greater public understanding of the many ways in which smoking harms the human body."
There's still some time before the images might appear on products, however, since other legal appeals are ongoing, the AP noted.
The U.S. Food and Drug Administration has also stated that it has no plans to update packaging requirements until at least December of 2025.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-26 06:00
Read more
- Ozempic Curbs Kidney Disease in Obese People Without Diabetes
- Can Cannabis Change Your Brain? Maybe, Maybe Not
- Ordinal Score Predicts Freedom From Epilepsy One Year After Surgery
- U.S. Diabetes Rates Rise to Nearly 1 in 6 Adults
- Newer Blood Thinner, Edoxaban, Cuts Odds for Stroke After Heart Valve Surgery
- FDA Approves Imkeldi (imatinib) Oral Solution for the Treatment of Certain Forms of Leukemia and Other Cancers
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions